One of the major complaints about psychiatric diagnoses is that there are no lab tests or x-ray findings to confirm a diagnosis, so we rely entirely upon an interview with the patient and certain key ...

A new study suggests low levels of a specific biomarker in your blood is linked to the severity and duration of depression. The collaborative study conducted by Stanford University and The Rockefeller ...

A group of researchers from Stanford in collaboration with other universities have found that in humans a low level of acetyl-L-carnitine or L-acetyle carnitine in blood could be a predictor of the ...

Depression could one day be diagnosed with a blood test, according to a study that has found a link between depression and a molecule in the body. A team of U.S. researchers found patients with major ...

Please provide your email address to receive an email when new articles are posted on . Women, but not men, at risk for or who have early dementia exhibited free carnitine deficiency. Free-carnitine ...

Reactivation Versus Clearance of Mycobacterium tuberculosis Using Mammalian Target of Rapamycin Inhibitors in Patients With Cancer Can Be Context Dependent There was no evidence that ALC affected CIPN ...

Approximately one-third of people with major depression don’t experience relief from existing methods of treatment. It affects 3.2 million patients in the United States alone, which is why researchers ...

ALCAR is a naturally occurring substance. It can be metabolized to acetyl-COA by the carnitine transferase reaction and may serve as an alternative source of fuel for the citric-acid cycle, thus ...

Severe dementia, neuropathies (painful nerves), mood disorders, attention deficit, and minor memory issues like inability to remember important dates or events are common problems. Acetyl-L-Carnitine ...

Low blood levels of acetyl-L-carnitine (LAC) may be a biomarker for major depressive disorder (MDD), new research suggests. The study, which included 116 participants, showed that both men and women ...

A prospective study to evaluate the efficacy and safety of oral acetyl-L-carnitine (ALC) in treatment of chemotherapy-induced peripheral neuropathy (CPIN). This is an ASCO Meeting Abstract from the ...